S109 Treating eosinophilic exacerbations of asthma and COPD with benralizumab: a double blind, double dummy, active-placebo controlled randomised trial (ABRA)
Ramakrishnan S., Russell REK., Mahmood HR., Krassowska K., Melhorn J., Mwasuku C., Pavord ID., Bermejo-Sanchez L., Howell I., Mahdi M., Peterson S., Bengtsson T., Bafadhel M.